製品の概要

  • 製品名Vecuronium bromide
  • 製品の詳細
    Competitive nicotinic acetylcholine receptor (nAChR) antagonist
  • 生理活性の詳細Competitive nicotinic acetylcholine receptor (nAChR) antagonist (IC50 = 9.9 nM). Muscle relaxant. Inhibits neural response to hypoxia.

製品の特性

    Vecuronium bromide (ab120536) 使用論文

    This product has been referenced in:
    • Liu M & Dilger JP Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor. Mol Pharmacol 75:166-73 (2009). Read more (PubMed: 18842832) »
    • Dilger JP  et al. Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists. Anesthesiology 106:1186-95 (2007). Read more (PubMed: 17525594) »
    • Igarashi A  et al. Vecuronium directly inhibits hypoxic neurotransmission of the rat carotid body. Anesth Analg 94:117-22, table of contents (2002). Read more (PubMed: 11772812) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120536.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"